Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection and Treatment Benefit of Microorganism (Chlamydia Trachomatis, Mycoplasma Hominis, Ureaplasma Urealyticum) in Overactive Bladder Patients

NCT00883818 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT00883818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00883818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection and Treatment Benefit of Microorganism (Chlamydia Trachomatis, Mycoplasma Hominis, Ureaplasma Urealyticum) in Overactive Bladder Patients
Lead sponsor
Samsung Medical Center
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2007
Completion date
December 31, 2007
Enrollment
84 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder